Results 71 to 80 of about 165,283 (121)

Risk management plans and drug safety in Canada: A cross-sectional study. [PDF]

Int J Risk Saf Med
Lexchin J.
europepmc   +1 more source

Relação dos livros recebidos em intercâmbio com a revista Alfa [PDF]

, 2001
Revista Alfa, Alfa, Revista
core   +2 more sources

OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy. [PDF]

Invest Ophthalmol Vis Sci
Huang WC, Ohnsman CM, Atiskova Y, Falabella P, Spitzer MS, Schulz A, Dulz S.   +6 more
europepmc   +1 more source

The expanding role of protease therapeutics (2012-2026): from replacement therapies to immune system modulation and beyond. [PDF]

Biochem J
Nelson SE, Martinusen SG, Pho R, Long LF, Denard CA.   +4 more
europepmc   +1 more source

Peripapillary Retinal Nerve Fiber Layer (pRNFL) Thickness - A Novel Biomarker of Neurodegeneration in Late-Infantile CLN2 Disease. [PDF]

Eye Brain
Gkalapis N, Dulz S, Grohmann C, Nickel M, Schwering C, Wibbeler E, Spitzer MS, Schulz A, Atiskova Y.   +8 more
europepmc   +1 more source

Enzyme Replacement Therapy for CLN2 Disease: MRI Volumetry Shows Significantly Slower Volume Loss Compared with a Natural History Cohort. [PDF]

AJNR Am J Neuroradiol
Gaur P, Gissen P, Biswas A, Mankad K, Sudhakar S, D'Arco F, Schulz A, Fiehler J, Sedlacik J, Löbel U.   +9 more
europepmc   +1 more source

Access to Orphan Medicinal Products in Bulgaria: An Analysis of the Positive Drug List and Individual Access Schemes. [PDF]

Healthcare (Basel)
Stefanov R, Raycheva R, Kostadinov K, Stefanov G, Zdravkova-Aneva I, Dzhambazova E, Iskrov G.   +6 more
europepmc   +1 more source

Apresentação

, 2009
Alfa, Revista
core   +1 more source

Evolution of Movement Disorders in Patients With CLN2-Batten Disease Treated With Enzyme Replacement Therapy. [PDF]

Neurology
Spaull R, Soo AK, Batzios S, Footitt E, Whiteley R, Mink JW, Carr L, Gissen P, Kurian MA.   +8 more
europepmc   +1 more source

Exploring the potential of natural history studies for rare neurological diseases. [PDF]

Ann Med Surg (Lond)
Muili AO, Gomez A, Sulaiman AO, Mutata S, Akhunji MT, Teemer A, Shahzad A, Kuol PP.   +7 more
europepmc   +1 more source